Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better.

From the week of July 28th, we are planning to work on 18 projects, including:

Reimbursement

1. Delivering a high-level overview of market access pathways for in-vitro diagnostics in England, France, Germany, Italy, and Spain
2. Delivering a high-level overview of market access pathways for in-vitro diagnostics in 11 European countries
3. Delivering reimbursement analysis for technology in the dermatology area in England, Germany, and Italy
4. Delivering reimbursement analysis for gastrointestinal endoscopic technology in Denmark, Norway, and Sweden
5. Working on market access strategy for the administration of a medication in outpatient settings in England, France, Germany, and Sweden
6. Working on reimbursement analysis for diagnostic tests in the neurology area in England, France, Germany, Italy, and Spain
7. Working on reimbursement analysis for minimally invasive cardiovascular technology in 11 European countries
8. Working on reimbursement analysis for cardiovascular surgical procedures in England, France, Germany, and Italy
9. Initiating work on reimbursement analysis for molecular diagnostic technologies in 12 European countries
10. Initiating work on reimbursement analysis for neurovascular technologies in eight European countries
11. Initiating work on coding mapping for cardiac, gastrointestinal, and peripheral vascular procedures in Finland, Norway, and Sweden

HEOR

1. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain 
2. Working on the development of an early value dossier for wound treatment technology in European countries 
3. Working on the early health economic analysis for wound treatment in England
4. Working on a systematic review and meta-analysis for an in vitro diagnostic test
5. Working on evidence gap analysis for in vitro diagnostic tests in the neurology area 
6. Working on the adaptation of the health economic model of treatment technology in the neurology area for Norway
7. Working on clinical value dossier for in vitro diagnostic test in the neurology area 

Let us know if you need any market access or HEOR support for your medical technology in Europe.